Related Experiment Video
Updated: Dec 5, 2025

08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.5K
Chasing the Dragon: Driving the Paradigm Shift to Move Beyond Opioids
1University of Maryland School of Medicine, Department of Physical Therapy and Rehabilitation Science, Baltimore, MD.
The Journal of Orthopaedic and Sports Physical Therapy
|October 20, 2020
Summary
The pursuit of passive pain relief with opioids is dangerous. Prioritizing exercise and physical rehabilitation as first-line treatments can reduce opioid use and save lives.
Area of Science:
- Pain Management
- Public Health
- Musculoskeletal Conditions
Background:
- The term "chasing the dragon" historically refers to opium use and now metaphorically describes the elusive goal of rapid, effective, and safe passive pain treatment.
- The United States faces a severe opioid crisis, partly due to a cultural expectation of quick, physician-provided pain relief.
- Pharmaceuticals cannot cure injuries or underlying causes of chronic musculoskeletal conditions.
Purpose of the Study:
- To challenge the reliance on passive, pharmaceutical pain management.
- To advocate for exercise and physical rehabilitation as primary pain treatment strategies.
- To highlight the potential of opioid-naïve approaches in reducing opioid-related harm.
Main Methods:
- Review of current pain management practices and cultural attitudes towards pain relief.
- Analysis of the effectiveness of exercise and physical rehabilitation versus passive care.
- Examination of the impact of first-line pharmaceutical pain management on the opioid crisis.
Main Results:
- Regular exercise is associated with reduced pain.
- Guidelines increasingly recommend exercise therapies over passive care for painful chronic conditions.
- Early guided physical rehabilitation is linked to lower healthcare costs and reduced opioid medication use.
Conclusions:
- Self-care approaches centered on exercise are the most logical, cost-effective, first-line treatment for pain.
- A shift in attitudes, behaviors, and policies is necessary to move away from first-line pharmaceutical pain management.
- Prioritizing exercise and physical rehabilitation can significantly reduce opioid dependency and save lives globally.
Related Concept Videos
Analgesia and Pain Management
1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
740
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
740
Opioid Analgesics: Morphine and Other Natural Cogeners
646
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
646
Opioid Receptors: Overview
3.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.4K
Pain
1.1K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.1K
Nociception
32.6K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.6K

